Insider Trading History of Laponis Adam

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Laponis Adam since 2022. This trader's CIK number is 1827198. At the time of last reporting, Laponis Adam was the Chief Financial Officer of Twist Bioscience Corp. (stock ticker symbol TWST). Also see all insider trading activities at Twist Bioscience Corp.

Note that in the past Laponis Adam also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Eargo, Inc. (EAR) by Laponis Adam

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 EAR 0 $0 59 $304 0 $0
2022 EAR 0 $0 687 $356 0 $0

Yearly summary of insider trading at Twist Bioscience Corp (TWST) by Laponis Adam

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 TWST 0 $0 9,253 $371,899 0 $0
2024 TWST 0 $0 1,698 $76,975 0 $0


Insider trading activities at 2 companies by Laponis Adam:

1. Eargo, Inc. (EAR)

2. Twist Bioscience Corp (TWST)

Table 1. Insider trading of Eargo, Inc. (EAR) by Laponis Adam

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-08-17 EAR Sale 19 3.23 61
2023-05-17 EAR Sale 19 4.69 89
2023-02-17 EAR Sale 21 7.37 154
2022-11-17 EAR Sale 687 .52 356

Table 2. Insider trading of Twist Bioscience Corp (TWST) by Laponis Adam

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-21 TWST Sale 918 25.96 23,834
2025-07-09 TWST Sale 2,449 38.15 93,419
2025-01-10 TWST Sale 5,886 43.26 254,646
2024-10-09 TWST Sale 856 41.81 35,791
2024-07-09 TWST Sale 842 48.91 41,184

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Laponis Adam (Chief Financial Officer of Twist Bioscience Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.